Shoulder Innovations, Inc.
Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company focused on shoulder surgery, offering implant systems and related technologies and support for shoulder arthroplasty to surgeons, hospitals and ambulatory surgery centers. Its portfolio includes interchangeable systems for anatomic… From the company’s description.
In fiscal 2025, Shoulder Innovations, Inc. reported revenue of $47.32M and a net loss of $40.36M. Its operating margin was −55.6%, and operations used $28.61M in cash. Over the twelve months to Sep 30, 2026, revenue was $64.49M.
Dotted labels explain each measure. is shown separately from the annual figures.
What Shoulder Innovations, Inc. does
In the company’s own words
Shoulder Innovations, Inc. (NYSE: SI) is a commercial-stage medical technology company focused on shoulder surgery, offering implant systems and related technologies and support for shoulder arthroplasty to surgeons, hospitals and ambulatory surgery centers. Its portfolio includes interchangeable systems for anatomic and reverse total shoulder arthroplasty, built around its InSet Glenoid and humeral stem technologies; ProVoyance, an AI-enabled tool that converts CT images into 3D models for patient-specific preoperative planning; and a two-tray instrument system designed for both procedures. The company also provides specialized case support and surgeon education through its Customer Experience and Medical Education team and independent distributors. Shoulder Innovations reports one operating segment. It began developing its InSet Glenoid in 2009, received FDA clearance in 2011 and launched its first anatomic system in 2016; it has since expanded its implant and planning offerings. In 2025, its implants were used in more than 17,500 procedures since launch, and it had 45 specialists across its commercial leadership and education teams as of December 31, 2025. Its website is https://shoulderinnovations.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- GRAND RAPIDS, MI
- Fiscal year end
- December
- CIK
- 1699350
- SIC
- 3841
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Shoulder Innovations, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Shoulder Innovations, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Shoulder Innovations, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Shoulder Innovations, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Shoulder Innovations, Inc.'s last four quarterly filings that the numbers alone won't show?”